Novel remedies with the use of beta 3 agonist
作者： Kohei Ogawa , Hiroshi Umeno
DOI:
关键词:
摘要: Provided is a therapeutic agent comprising at least one member selected from the group consisting of an anticholinergic agent, monoamine reuptake inhibitor, lipase selective serotonin insulin, insulin secretagogue, biguanide, α-glucosidase resistance improving HMG-CoA reductase anion exchange resin, clofibrate type drug and nicotinic acid drug, compound having β3 agonist activity. The β3-agonist has activity inhibiting dysuria. Further, when used together with remedy for dysuria such as propiverine, oxybutynin hydrochloride or tolterodine, it exerts enhanced anti-dysuria effect. When antiobestic sibutramine orlistat, antidiabetic glibenclamide, acarbose rosiglitazone, antilipemic bezafibrate pravastatin,
lens.org 参考文章(27)
Ann E. Weber, Hyun Ok, Michael H. Fisher, Dong Ok, Thomas Shih, Elisabeth M. Naylor, SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY ,(1995)
Brian Roy Bailey Crescent Holloway, Ralph Little Beck Upton Howe, Balbir Singh Rao, 4-[2-(2-hydroxy-2-phenylethylamino)ethyl]phenylacetic acid as beta3-adrenoceptor-agonist ,(1993)
Charles Advenier, Luciano Manara, Therapeutic use of compounds with β3-agonist activity ,(1999)
Kohei Ogawa, Shiro Miyoshi, Novel tricyclic compounds and drug compositions containing the same ,(1996)
Jonathan Robert Sanders Arch, Combinations comprising a beta-agonist and a further antidiabetic agent ,(1999)
Brian S. Muehl, Thomas A. Crowell, Anthony J. Shuker, Andrew J. Thorpe, Christopher J. Rito, Charles D. Jones, Kenneth J. Thrasher, Deborah A. Evrard, Carbazolyl-substituted ethanolamines as selective β-3 agonists ,(1997)
Nobuyuki Yasuda, Susumu Tsuchiya, Toshifumi Matsumoto, Kouichi Matsunaga, Kozo Hiratsuka, Hiroyuki Iizuka, Atsusi Hukuzaki, Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same ,(1996)
William N. Washburn, Kathleen M. Poss, Amarendra B. Mikkilineni, Philip M. Sher, Gregory S. Bisacchi, Ravindar N. Girotra, Arvind Mathur, Ashvinikumar Gavai, CATECHOLAMINE SURROGATES USEFUL AS β3 AGONISTS ,(1994)
Emma R. Parmee, Ann E. Weber, Hyun Ok, Michael H. Fisher, Thomas Shih, Elizabeth M. Naylor, Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity ,(1996)
Emma R. Parmee, Robert J. Mathvink, Ann E. Weber, Samuel Tolman, Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity ,(1998)